Atrial fibrillation causes ischemic strokes, specifically the subtype known as cardioembolic stroke. This happens when a blood clot forms in the heart’s upper chambers and travels to the brain, blocking a cerebral artery. Having atrial fibrillation increases ischemic stroke risk fivefold, and in the United States alone, this irregular heart rhythm is responsible for more than 70,000 ischemic strokes each year.
How AFib Creates Blood Clots
During atrial fibrillation, the upper chambers of the heart quiver instead of contracting fully. This disorganized movement slows blood flow, allowing it to pool and stagnate. The clots that form almost always develop in a small, finger-shaped pouch called the left atrial appendage. About 90% of blood clots in people with non-valvular atrial fibrillation originate in this structure.
The left atrial appendage is particularly vulnerable because of its shape and ridged inner walls. In a normally beating heart, blood moves through it quickly enough to prevent clotting. In atrial fibrillation, flow velocities inside the appendage drop significantly, with studies linking very low flow speeds to a much higher risk of clot formation. Once a clot forms and breaks loose, it enters the bloodstream and can lodge in an artery supplying the brain, cutting off oxygen to brain tissue.
Why Cardioembolic Strokes Are More Dangerous
Not all ischemic strokes are equally severe. Cardioembolic strokes tend to produce larger areas of brain damage because the clots originating from the heart are often bigger than those forming in narrowed neck or brain arteries. These clots frequently block major arteries, causing large cortical strokes that affect significant portions of the brain.
The numbers reflect this. One-year survival after a cardioembolic stroke is roughly 58%, compared to 82% for strokes caused by large artery disease and 94% for small vessel strokes. Even after adjusting for age and initial stroke severity, cardioembolic strokes carry 3.4 times the mortality risk of small vessel strokes. People who suffer cardioembolic strokes also arrive at the hospital with worse neurological deficits on average, scoring a mean of 10.1 on the standard stroke severity scale versus 3.8 for small vessel strokes.
Silent AFib and “Mystery” Strokes
About 25% of ischemic strokes are initially classified as having no identifiable cause. These are called cryptogenic strokes, and a substantial portion turn out to be caused by atrial fibrillation that was never detected. The challenge is that AFib can come and go, sometimes lasting only minutes, and roughly 87% of first episodes produce no symptoms at all.
When researchers implanted long-term heart monitors in cryptogenic stroke patients, they found hidden atrial fibrillation in 29% of them within the first year. By four years, that number climbed to 37%. This means that many people who have a stroke don’t know they have atrial fibrillation until after the damage is done. Strokes affecting the front part of the brain and those involving the brain’s outer surface are stronger predictors that silent AFib is the underlying cause.
How Blood Thinners Prevent AFib Strokes
Because these strokes originate from blood clots, prevention centers on anticoagulant medications (blood thinners) that make clot formation less likely. The current standard of care for most people with non-valvular atrial fibrillation is a class of drugs called direct oral anticoagulants, which have largely replaced warfarin as the first choice. These newer medications require less monitoring and have fewer dietary restrictions than warfarin, though warfarin remains the standard for people whose AFib is related to heart valve disease.
Whether you need blood thinners depends on your overall stroke risk, which doctors estimate using a scoring system called CHA2DS2-VASc. It assigns points based on common risk factors:
- Heart failure: 1 point
- High blood pressure: 1 point
- Age 75 or older: 2 points
- Diabetes: 1 point
- Previous stroke or TIA: 2 points
- Vascular disease (prior heart attack or peripheral artery disease): 1 point
- Age 65 to 74: 1 point
- Female sex: 1 point
Current guidelines from the American College of Cardiology and American Heart Association recommend anticoagulation for men scoring 2 or higher and women scoring 3 or higher. For people just below those thresholds, blood thinners are still considered reasonable. The annual stroke risk for someone with AFib ranges from 1% to 20% depending on how many of these factors are present, which is why the decision is individualized rather than automatic.
Options When Blood Thinners Aren’t Possible
Some people can’t take long-term blood thinners because of bleeding disorders, frequent falls, or other medical reasons. For these patients, a procedure to physically seal off the left atrial appendage offers an alternative. Since this pouch is where the vast majority of clots form, closing it off can significantly reduce stroke risk without ongoing medication.
The most widely used device for this in the United States is a small, umbrella-shaped implant that a cardiologist delivers through a catheter threaded from the leg to the heart. It was approved by the FDA in 2015 for people with AFib who are at elevated stroke risk but have valid reasons for avoiding long-term anticoagulation. One important limitation: the procedure still requires a short course of blood thinners afterward while the device heals into place, so people who cannot tolerate even brief anticoagulation are not candidates.
Guidelines from multiple cardiology societies also recommend this approach for patients who have suffered strokes despite taking blood thinners as prescribed, or for those with a high likelihood of not taking their medication consistently.